Abortion Pill Access Threat Renewed by Red States, Federal Study
Bloomberg Law, September 24, 2025
Texas, Florida, and Louisiana are urging U.S. District Judge Matthew Kacsmaryk of the Northern District of Texas to let them join Missouri v. FDA, a lawsuit by three other red states seeking to force the Food and Drug Administration to drop telemedicine access to the abortion medication mifepristone and further restrict its use … “Texas and Florida are not only asking the court to make it harder for people nationwide to get mifepristone – they have also asked Judge Kacsmaryk to take this essential medication off the market entirely in every state in the country,” [Julia] Kaye said.
RFK Jr. Launches FDA Review of Abortion Pill
ABC News, September 24, 2025
Health and Human Services Secretary Robert F. Kennedy Jr. told Republican states this week that the FDA would conduct a new review of abortion pills, a move that abortion rights advocates say could lead to significant restrictions on the most common abortion method nationwide … Kiki Freedman, co-founder and CEO of Hey Jane, the largest telemedicine abortion provider in the country, told ABC News on Wednesday that the new HHS review could “undermine access to one of the most thoroughly studied and widely used medications in the country.”
Reproductive Justice Advocates Warn of Health Care Crisis in Louisiana Following Planned Parenthood Shutdown
Verite News, September 22, 2025
Planned Parenthood’s health centers in New Orleans and Baton Rouge will shut down indefinitely at the end of this month … Sixty percent of patients served at Planned Parenthood’s Louisiana clinics are Medicaid insurance users and 71% are people of color. In the last five years the New Orleans and Baton Rouge clinics have seen close to 46,000 patients, according to the company … “This will affect someone you love,” [Victoria Coy] said. “This is breast cancer, this is ovarian cancer, this is wanted pregnancy. All of those things will now result in greater rates of death, harm and maiming.”
Pregnant Women Are Pressured To ‘Tough It Out,’ Even by the President
The New York Times, September 24, 2025
This week, President Trump emphatically discouraged women from taking Tylenol during pregnancy, based on unproven claims that acetaminophen is linked to autism … Dr. Linda Eckert, a professor of obstetrics and gynecology at the University of Washington, said she worried that the president’s announcement was “going to raise more fears” and add to the sense that it is appropriate for women to suffer for the sake of their babies. “Now they’re being told, ‘Oh if you ask for pain medicine, and you ask for Tylenol, then you’re just not tough enough.’”
Birth Control Among US Therapies Most at Risk From Trump’s 250% Tariff Threat
Bloomberg, September 23, 2025
US President Donald Trump’s threat of imposing tariffs as high as 250% on pharmaceutical imports is putting cheap supplies from Indian drugmakers at risk, with commonly prescribed oral contraceptives at the top of the list … With over 65% of US women between the ages of 15 and 49 relying on pregnancy prevention drugs, family planning concerns are paramount but “just the tip of the iceberg,” [Kim Villanueva] said. Any disruption in supplies could “contribute to broader health care costs to manage other health issues,” Villanueva said, noting these pills are also prescribed for treatments such as period regulation, managing endometriosis and migraines.
ICYMI: In Case You Missed It
The history of executive order 11246, which spans nearly nine decades, shows us that President Trump’s attacks will not stop our ongoing fight for workplace civil rights and equal employment opportunities.
We respect your privacy. Read our policy.
Note: The information contained in this publication reflects media coverage of women’s health issues and does not necessarily reflect the views of the National Partnership for Women & Families.
